Trulicity
Trial win sets up filings for Lilly’s diabetes blockbuster hope tirzepatide
Phil Taylor
Diabetes, Eli Lilly, Novo Nordisk, Ozempic, tirzepatide, Trulicity, Type 2 diabetes
0 Comment
News/ News/ Sales and Marketing
Lilly raises 2020 earnings forecast on pandemic stockpiling
Phil Taylor
Basaglar, coronavirus, Eli Lilly, financial results, Humalog, Taltz, Trulicity
0 Comment
FDA approves MACE label claim for Lilly’s Trulicity
Phil Taylor
Diabetes, Eli Lilly, Novo Nordisk, Ozempic, Rybelsus, Trulicity
0 Comment
News/ News/ Sales and Marketing
Ozempic acceleration buoys Novo Nordisk, and threatens Lilly
Phil Taylor
Diabetes, Eli Lilly, financial results, Novo Nordisk, Ozempic, Rybelsus, Saxenda, Trulicity
0 Comment
News/ News/ Sales and Marketing/ Top stories
Lilly’s diabetes med Trulicity shrugs off Novo Nordisk challenge
Phil Taylor
Diabetes, Eli Lilly, financial results, Novo Nordisk, Ozempic, Rybelsus, Trulicity
0 Comment
News/ News/ R&D/ Sales and Marketing
Trulicity helps SGLT-2 patients lower blood sugar
Andrew McConaghie
Diabetes, Eli Lilly, Novo Nordisk, Ozempic, Trulicity, Type 2 diabetes
0 Comment
New phase 3b trial results show Lilly’s Trulicity combined with an SGLT2 inhibitor failed to show any benefits above and beyond Trulicity’s blood glucose lowering.
New drugs boost Lilly in Q1 as company hopes for turnaround year
Richard Staines
Cymbalta, Diabetes, Jardiance, Lilly, Trulicity
0 Comment